HTG Molecular Diagnostics Establishes Immuno-Oncology Scientific Advisory Board
TUCSON, Ariz., Feb. 16, 2016 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), please note that in the header for the fourth paragraph of the release, the HTG SAB member should be Ignacio I. Wistuba, M.D. and not Ignatio I. Wistuba, M.D. as previously stated. The corrected release follows:
HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced the establishment of a Scientific Advisory Board (“SAB”) of distinguished leaders in the field of immuno-oncology. The newly formed SAB will serve as a resource to HTG in the development of immuno-oncology applications and biomarker panels for the assessment of the host immune response to tumors.
- Press Releases